| 1 |
33428168 | Pharmacokinetics of Rosuvastatin: A Systematic Review of Randomised Controlled Trials in Healthy Adults. | 2021 Feb |
1 |
| 2 |
30290001 | Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders. | 2019 Apr |
1 |
| 3 |
30942448 | Potentiation of mitotane action by rosuvastatin: New insights for adrenocortical carcinoma management. | 2019 Jun |
2 |
| 4 |
29533074 | Analytical Methods for the Determination of Rosuvastatin in Pharmaceutical Formulations and Biological Fluids: A Critical Review. | 2018 Jul 4 |
2 |
| 5 |
29692602 | Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers. | 2018 |
1 |
| 6 |
27941393 | Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease. | 2017 Feb 20 |
1 |
| 7 |
25719441 | Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers. | 2016 Nov/Dec |
1 |
| 8 |
26908399 | Varicose Remodeling of Veins Is Suppressed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors. | 2016 Feb 23 |
1 |
| 9 |
26930419 | Rosuvastatin: Beyond the cholesterol-lowering effect. | 2016 May |
1 |
| 10 |
25453767 | HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS. | 2015 Jan 22 |
2 |
| 11 |
25767372 | A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects. | 2015 |
1 |
| 12 |
26081159 | Marked Alteration of Rosuvastatin Pharmacokinetics in Healthy Chinese with ABCG2 34G>A and 421C>A Homozygote or Compound Heterozygote. | 2015 Sep |
1 |
| 13 |
26093357 | Identification of transformation products of rosuvastatin in water during ZnO photocatalytic degradation through the use of associated LC-QTOF-MS to computational chemistry. | 2015 Dec 15 |
2 |
| 14 |
26411232 | Transient azoospermia following rosuvastatin medication for hypercholesterolemia. | 2015 |
2 |
| 15 |
25128668 | Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. | 2014 Oct 6 |
2 |
| 16 |
23256625 | Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design. | 2013 Jun |
1 |
| 17 |
23447089 | Effect of food on the pharmacokinetics of rosuvastatin after administration of a single oral dose in dogs. | 2013 Mar |
1 |
| 18 |
24137286 | Rosuvastatin suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation and migration via the MAPK signaling pathway. | 2013 Oct |
1 |
| 19 |
22442638 | Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease. | 2012 |
1 |
| 20 |
21881526 | Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation. | 2011 Oct |
1 |
| 21 |
19956889 | Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. | 2010 Jan |
1 |
| 22 |
20653359 | Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. | 2010 Aug |
1 |
| 23 |
21701608 | Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemics. | 2009 |
1 |
| 24 |
17692320 | The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. | 2008 Feb |
1 |
| 25 |
18177480 | In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin. | 2008 May |
1 |
| 26 |
18355422 | The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics. | 2008 Apr |
1 |
| 27 |
17577102 | Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells. | 2007 Jun |
1 |
| 28 |
16581327 | Statin safety: an appraisal from the adverse event reporting system. | 2006 Apr 17 |
1 |
| 29 |
16128507 | Rosuvastatin: a high-potency HMG-CoA reductase inhibitor. | 2005 Jul-Aug |
1 |
| 30 |
16144509 | Rosuvastatin: a risk-benefit assessment for intensive lipid lowering. | 2005 Sep |
1 |
| 31 |
15137986 | Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection. | 2004 May 28 |
1 |
| 32 |
12534645 | Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. | 2003 Jan |
1 |
| 33 |
12682802 | The effect of erythromycin on the pharmacokinetics of rosuvastatin. | 2003 May |
1 |
| 34 |
12709722 | Effect of itraconazole on the pharmacokinetics of rosuvastatin. | 2003 Apr |
1 |
| 35 |
12773150 | Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin. | 2003 Jun |
1 |
| 36 |
12824720 | Rosuvastatin--a highly effective new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor: review of clinical trial data at 10-40 mg doses in dyslipidemic patients. | 2003 |
1 |
| 37 |
14512129 | A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers. | 2003 Aug |
1 |
| 38 |
14667956 | Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. | 2003 Oct |
1 |
| 39 |
14693307 | Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. | 2003 Nov |
1 |
| 40 |
14983742 | [Dyslipidemia and global cardiovascular risk: treatment guidelines]. | 2003 Dec |
1 |
| 41 |
14983747 | [Ongoing trials and future prospects]. | 2003 Dec |
1 |
| 42 |
15030249 | Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia. | 2003 Nov |
2 |
| 43 |
11772327 | Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia. | 2002 Jan |
1 |
| 44 |
12269853 | Rosuvastatin. | 2002 |
1 |
| 45 |
12445025 | Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers. | 2002 Nov |
1 |
| 46 |
12481202 | Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor. | 2002 Winter |
2 |
| 47 |
12769127 | Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia. | 2002 Mar |
1 |